Baker Bros. Advisors Lp Atreca, Inc. (BCEL) insider trading activity

BAKER BROS. ADVISORS LP Transaction History

Date	Transaction	Value	Shares Traded	Form
Oct 19 2023	SELL Open market or private sale	$109,895 $0.4 p/Share	274,739
Jun 24 2019	BUY Conversion of derivative security	-	3,532,760

Also insider at

INCY

INCYTE CORP Healthcare

GHDX

GENOMIC HEALTH INC

Director

IDRA

IDERA PHARMACEUTICALS, INC. Healthcare

> 10% Shareholder

RYTM

RHYTHM PHARMACEUTICALS, INC. Healthcare

BGNE

BeiGene, Ltd. Healthcare

Director

ACAD

ACADIA PHARMACEUTICALS INC Healthcare

MRTX

Mirati Therapeutics, Inc. Healthcare

BLCM

BELLICUM PHARMACEUTICALS, INC Healthcare

> 10% Shareholder

SGEN

Seagen Inc. Healthcare

Director

NVTA

Invitae Corp Healthcare

> 10% Shareholder

ALXN

ALEXION PHARMACEUTICALS, INC.

Director

NLTX

Neoleukin Therapeutics, Inc. Healthcare

Director

KNSA

Kiniksa Pharmaceuticals, Ltd. Healthcare

Director

KOD

Kodiak Sciences Inc. Healthcare

Director

HOOK

HOOKIPA Pharma Inc. Healthcare

IGMS

IGM Biosciences, Inc. Healthcare

ZYME

Zymeworks Inc. Healthcare

Director

PRLD

Prelude Therapeutics Inc Healthcare

Director

TLIS

Talis Biomedical Corp Healthcare

Director

AGLE

Aeglea BioTherapeutics, Inc. Healthcare

Director

TCRX

TScan Therapeutics, Inc. Healthcare

TRDA

Entrada Therapeutics, Inc. Healthcare

> 10% Shareholder

DBVT

DBV Technologies S.A. Healthcare

Director

MDGL

MADRIGAL PHARMACEUTICALS, INC. Healthcare

VTVT

vTv Therapeutics Inc. Healthcare

KYMR

Kymera Therapeutics, Inc. Healthcare

BCYC

BICYCLE THERAPEUTICS plc Healthcare

IMCR

Immunocore Holdings plc Healthcare

BBA